Your browser doesn't support javascript.
loading
Use of Text Messaging (SMS) for the Management of Side Effects in Cancer Patients Undergoing Chemotherapy Treatment: a Randomized Controlled Trial.
Rico, Timóteo Matthies; Dos Santos Machado, Karina; Fernandes, Vanessa Pellegrini; Madruga, Samanta Winck; Santin, Mateus Madail; Petrarca, Cristiane Rios; Dumith, Samuel Carvalho.
Afiliação
  • Rico TM; Instituto Federal Sul-Rio-Grandense, Corredor das Tropas, 801, Jaguarão - Rio Grande do Sul, Jaguarão, RS, 96300-000, Brazil. timoteomr@gmail.com.
  • Dos Santos Machado K; C3 - Centro de Ciências Computacionais, Universidade Federal do Rio Grande, Rio Grande do Sul, Rio Grande, Brazil.
  • Fernandes VP; Hospital Escola, Universidade Federal de Pelotas, Rio Grande do Sul, Pelotas, Brazil.
  • Madruga SW; Hospital Escola, Universidade Federal de Pelotas, Rio Grande do Sul, Pelotas, Brazil.
  • Santin MM; Hospital Escola, Universidade Federal de Pelotas, Rio Grande do Sul, Pelotas, Brazil.
  • Petrarca CR; Hospital Escola, Universidade Federal de Pelotas, Rio Grande do Sul, Pelotas, Brazil.
  • Dumith SC; Programa de Pós Graduação em Ciências da Saúde, Universidade Federal do Rio Grande, Rio Grande do Sul, Rio Grande, Brazil.
J Med Syst ; 44(11): 193, 2020 Sep 30.
Article em En | MEDLINE | ID: mdl-32996027
Cancer patients are often not sufficiently oriented to manage side effects at home. Sending text messages with self-care guidelines aimed managing side effects is the main objective of this randomized controlled trial. Patients who started outpatient chemotherapy treatment between March and December 2017 at a hospital in southern Brazil were invited to participate in this study and were allocated to the intervention or control group (ratio 1: 1). Each patient in the intervention group received a daily SMS (short message service) with some guidance on management or prevention of side effects. All text messages were sent to the intervention group patients in an automated and tailored way by our app called cHEmotHErApp. Side effects experienced by patients were verified using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30). Results showed intervention group patients experienced fewer side effects compared to the control group in cycle 1 (p < 0.05), in general. In addition, intervention group experienced less nausea in relation to the control group, in the cycle 1 and cycle 2 (p < 0.05). This study indicate text messaging may be a tool for supporting side effect management in patients receiving chemotherapy. This study was enrolled in ClinicalTrials.gov with the identification number NCT03087422. This research was performed in accordance with the Declaration of Helsinki.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envio de Mensagens de Texto / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Aspecto: Patient_preference Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Med Syst Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Envio de Mensagens de Texto / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Qualitative_research Aspecto: Patient_preference Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Med Syst Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Brasil País de publicação: Estados Unidos